Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006

J Heart Lung Transplant. 2006 Sep;25(9):1003-23. doi: 10.1016/j.healun.2006.06.007.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Cardiac Catheterization
  • Cardiac Output, Low / complications
  • Cardiac Output, Low / drug therapy*
  • Cardiac Output, Low / physiopathology
  • Cardiac Output, Low / therapy*
  • Cardiotonic Agents
  • Coronary Artery Bypass
  • Disease Management
  • Exercise
  • Heart Transplantation*
  • Humans
  • Preoperative Care / methods*
  • Sleep Wake Disorders
  • Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
  • Terminal Care
  • Water-Electrolyte Balance / physiology

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Cardiotonic Agents
  • Sodium Potassium Chloride Symporter Inhibitors